RRML - Mathematical model to predict methotrexate elimination in children with acute lymphoblastic leukemia
Main page News RJLabM Credits Archive
Current issue Ahead of print List of published issues 202520242023202220212020201920182017201620152014201320122011201020092008200720062005
Instructions for authors Online applications Editorial About us Links  
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- April 2025 -
 
Romanian Review of Laboratory ... 11
Investigation of cytokine chan... 5
Association of neutrophil-to-l... 4
Small patients, big challenges... 3
A comparative study of legisla... 3
CALLY index, but not HALP scor... 3
Value of four-dimensional comp... 2
Recomandarea comună EFLM-COLA... 2
Understanding the pathogenesis... 2
Monocyte to high-density lipop... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 22(1)/2014 DOI:10.2478/rrlm-2014-0012
XML
TXT

Mathematical model to predict methotrexate elimination in children with acute lymphoblastic leukemia

Laurenţiu Lucaci, Ștefana Maria Moisă, Marin Burlea, Lucian Miron


Abstract:

Introduction: Methotrexate, a structural analogue to the folic acid, is one of the most frequently used antimetabolites in pediatric oncologic pathology. Its mode of action and toxic effects are now well known. Material and method: Our study aimed to describe the quantitation of the drug in serum of 40 children with acute lymphatic leukemia receiving high doses of methotrexate and to predict serum methotrexate levels at 96 hours, based on 48 h, 72h levels and on alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, and creatinine serum levels. The above mentioned parameters were analyzed by sampling serum levels at 48h, 72h and 96 hours after methotrexate administration and a logical regression model being projected upon obtained results. Results and conclusions: methotrexate serum level at 96 hours does not depend on either AST, ALT, urea, creatinine levels or on the methotrexate level determined at 48 hours, it only depends on the methotrexate serum level at 72 hours.

Keywords: methotrexate serum level,toxicity

 
  PDF Download full text PDF
(369 KB)
  PDF Supplementary material
     
 
How to cite
Lucaci L, Moisă ȘM, Burlea M, Miron L. Mathematical model to predict methotrexate elimination in children with acute lymphoblastic leukemia. Rev Romana Med Lab. 2014;22(1):101-9. DOI:10.2478/rrlm-2014-0012